As of April 17, 2020, it was found 13 percent of British population thought that the government was handling the coronavirus (COVID-19) outbreak very well, this is a fall from a high point of 22 percent of Brits believing the situation was being handled very well at the end of March. According to the latest survey wave, the majority of respondents still feel the government is handling the crisis well, with 53 percent believing this to be the case.

In a survey carried in the UK in May 2020, Brit's perceived their country's handling of the coronavirus situation fairly average in comparison to some other countries. The survey found that there was a large amount of admiration for the way the coronavirus pandemic has been dealt with in Germany, with 21 percent of respondents of the opinion that the UK has handled the situation a little worse than Germany, and a further 30 percent said the UK has handled the situation a lot worse. On the other hand, 27 percent of Brits think the UK has tackled the crisis much better than the United States.

The latest number of cases in the UK can be found here. For further information about the coronavirus pandemic, please visit our dedicated Facts and Figures page.

According to a survey among Indians in March 2020, about 34 percent thought incoming travel should be limited for the month following the survey period. This included the opinion that travelers into India should only be allowed if they had a "coronavirus free" certificate from the country of departure or boarding port. With the outbreak of the coronavirus (COVID-19) in late 2019, countries across the world have implemented entry restrictions, quarantine measures and travel advisories to help contain the virus. As of March 13, 2020, the Indian government suspended existing visas with exceptions until April 15, 2020. The country went into lockdown on March 25, the largest in the world, restricting 1.3 billion people.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Fact and Figures page.

The COVID-19 Guidance Questionnaire The COVID-19 Guidance Questionnaire is published on Government website. The opinion he provides has no medical value: its goal is to direct the respondent according to his or her health and symptoms towards the right behavior to adopt. The algorithm used to propose guidance is in line with documentation published by the Ministry of Solidarity and Health, which reference also other solutions that comply with it. ### Data from the COVID-19 Guidance Questionnaire This data is published in open data to inform about the number of times the questionnaire has been completed to the end as well as the guidance messages sent. Data are grouped by week, department and age group. For each week/department/age class are indicated the number of responses obtained, the number of referrals to the UAS, the number of referrals to a consultation, and the number of messages indicating that the respondent should stay at home and monitor their health. The published ‘csv’ file will be updated weekly by adding the new data. The questionnaire was offline on 27 January 2021, so data runs until 26 January 2021.

The Response2covid19 dataset tracks governments’ responses to COVID-19 all around the world. The dataset is at the country-level and covers the January-October 2020 period; it is updated on a monthly basis. It tracks 20 measures – 13 public health measures and 7 economic measures – taken by 228 governments. The tracking of the measures allows creating an index of the rigidity of public health measures and an index of economic response to the pandemic. The objective of the dataset is both to inform citizens and to help researchers and governments in fighting the pandemic.The dataset can be downloaded and used freely. Please properly cite the name of the dataset (“Governments’ Responses to COVID-19 (Response2covid19)”) and the reference: Porcher, Simon "A novel dataset of governments' responses to COVID-19 all around the world", Chaire EPPP 2020-03 discussion paper, 2020.

In March 2020, it was found that 33 percent of Brits think the government's response to the coronavirus (COVID-19) outbreak has been too focused on protecting the country's economy in comparison to people's health. On the other hand, 16 percent feel the government is giving too much emphasis to protecting people's health over the economy, but 42 percent believe the government has got the balance about right. For further information about the coronavirus pandemic, please visit our dedicated Facts and Figures page.

This letter urges attorneys, courts, Court Improvement Programs, and administrative offices of the courts to work together to ensure that requisite judicial proceedings continue during the COVID-19 pandemic. Browse All COVID-19 Resources Metadata-only record linking to the original dataset. Open original dataset below.

As of March 2022, about **** percent of respondents stated that the Thai government should reduce cost of living during the COVID-19 pandemic in the country. Moreover, fast and convenient access to medical treatment was one of the suggestions for the government support during such time.

According to a global survey conducted in 2020, ** percent of respondents from Australia and New Zealandtrusted their national government had made most of their COVID-related decisions based on scientific advice, the highest share across all regions globally. This statistic presents the level of public trust in national governments worldwide to make COVID-related decisions based on scientific advice in 2020, by region.

NOTE: As of 12/17/2024, this dataset is no longer updated. Please use ASPR Treatments Locator. This dataset displays pharmacies, clinics, and other locations with safe and effective COVID-19 medications. These medications require a prescription from a healthcare provider. Some locations, known as Test to Treat sites, give you the option to get tested, get assessed by a healthcare provider, and receive treatment – all in one visit. COVID-19 medications may be available at additional locations that are not shown in this dataset. The locations displayed have either self-attested they have inventory of Paxlovid (nirmatrelvir packaged with ritonavir), Lagevrio (molnupiravir), or Veklury (Remdesivir) within at least the last two months and/or reported participation in the Paxlovid Patient Assistance Program. Sites that have not reported in the last two weeks display a notification, "Inventory has not been reported in the last 2 weeks. Please contact the provider to make sure the product is available." Outpatient COVID-19 medications may be available at additional locations not listed on this website. All therapeutics identified in the locator not approved by the FDA must be used in alignment with the terms of the respective product’s Emergency Use Authorization. Visit COVID-19 Treatments and Therapeutics for more information on all treatment options. This website identifies sites that have commercially purchased inventory of COVID-19 treatments and, in some cases, may identify sites that have remaining, no-cost U.S. government distributed supply. Some sites may charge for services not covered by insurance. Some sites may offer telehealth services. This website is intended for informational purposes only and does not serve as an endorsement or recommendation for use of any of the locations listed on the sites. Clarification for DoD Facilities: Those individuals eligible for care in an MTF include Active Duty Service Members (ADSMs), covered beneficiaries enrolled in TRICARE Prime or Select, including TRICARE Reserve Select (TRS), TRICARE Retired Reserve (TRR) and TRICARE Young Adult (TYA) participants, TRICARE for Life beneficiaries, and individuals otherwise entitled by law to MTF care (e.g., regular retired members and their dependents who are not enrolled in TRICARE but who are otherwise eligible for MTF space-available care, certain foreign military members and their families registered in DEERS, and others).

Additional file 4. Confirmed and Deaths Data.

This public use dataset has 11 data elements reflecting COVID-19 community levels for all available counties. This dataset contains the same values used to display information available at https://www.cdc.gov/coronavirus/2019-ncov/science/community-levels-county-map.html. CDC looks at the combination of three metrics — new COVID-19 admissions per 100,000 population in the past 7 days, the percent of staffed inpatient beds occupied by COVID-19 patients, and total new COVID-19 cases per 100,000 population in the past 7 days — to determine the COVID-19 community level. The COVID-19 community level is determined by the higher of the new admissions and inpatient beds metrics, based on the current level of new cases per 100,000 population in the past 7 days. New COVID-19 admissions and the percent of staffed inpatient beds occupied represent the current potential for strain on the health system. Data on new cases acts as an early warning indicator of potential increases in health system strain in the event of a COVID-19 surge. Using these data, the COVID-19 community level is classified as low, medium , or high. COVID-19 Community Levels can help communities and individuals make decisions based on their local context and their unique needs. Community vaccination coverage and other local information, like early alerts from surveillance, such as through wastewater or the number of emergency department visits for COVID-19, when available, can also inform decision making for health officials and individuals. See https://www.cdc.gov/coronavirus/2019-ncov/science/community-levels.html for more information. Visit CDC’s COVID Data Tracker County View* to learn more about the individual metrics used for CDC’s COVID-19 community level in your county. Please note that county-level data are not available for territories. Go to https://covid.cdc.gov/covid-data-tracker/#county-view. For the most accurate and up-to-date data for any county or state, visit the relevant health department website. *COVID Data Tracker may display data that differ from state and local websites. This can be due to differences in how data were collected, how metrics were calculated, or the timing of web updates.

This guidance update reflects changes made to the required data elements for reporting as well as the cadence with which these elements need to be reported to CDC’s National Healthcare Safety Network (NHSN) following the expiration of the federal COVID-19 public health emergency declaration. There are no significant changes or additions to the reporting questions as a result of this guidance update. Information on reporting to NHSN can be found here: https://www.cdc.gov/nhsn/covid19/hospital-reporting.html.

The impact of the coronavirus (COVID-19) pandemic on people, households and communities in Great Britain – indicators from the Opinions and Lifestyle Survey (OPN).